2011
DOI: 10.3233/jad-2011-102145 View full text |Buy / Rent full text
|
|

Abstract: Alzheimer's disease (AD) is the fastest growing neurodegenerative disease in the elderly population, and the search for therapeutic targets and diagnostic AD biomarkers is an exigent issue. Because amyloid-β (Aβ) aggregation constitutes the epicenter of AD pathology, Aβ-binding proteins that regulate Aβ aggregation, such as transthyretin (TTR), have attracted much attention. TTR binds to Aβ, prevents its aggregation, and consequently inhibits Aβ-induced cellular toxicity. Decreased TTR levels in cerebrospinal … Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
5
50
0
1

Publication Types

Select...

Relationship

0
0

Authors

Journals